Biosafety testing is a critical step in the drug development and manufacturing process, helping to ensure that biologics are safe, effective, and compliant with regulatory requirements. “This investment underscores Merck’s commitment to empowering medicine makers by providing industry-leading analytical and biosafety testing services and technical expertise.” “Merck’s expansion of the BioReliance® lab will bring world-class and next-generation testing services to biopharmaceutical companies in Singapore and the region. The Singapore BioReliance® lab was opened in 2018, and the expansion will bring the total lab area to over 1,000 square meters. Hashtag: #Merck #BioReliance #biosafety